Luis A. Rodriguez

Luis A. Rodriguez

Auto-generated profile, based on publicly available information

Luis A. Rodriguez

Kaiser Permanente Northern California, Division of Research, Pleasanton, CA, USA; Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science, Pasadena, CA, USA; University of California, San Francisco, Department of Epidemiology & Biostatistics, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2018 in Globalization and Health
Verified
Journal Article
Open access
PDF file
MGMexico-California Diabetes collaborative group
Mexico-California Diabetes collaborative group
SBSimón Barquera
Simón Barquera
DSDean Schillinger
Dean Schillinger
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
MSMarc Schenker
Marc Schenker
JSJaime Sepúlveda-Amor
Jaime Sepúlveda-Amor
Type 2 Diabetes (T2D) is now a massive epidemic in both California and Mexico, with serious consequences for social and economic well-being. A large proportion of these populations share common ethnic backgrounds. Yet diverse environmental and social conditions across regions create unique opportunities to explore the ways that T2D risk, incidence, management and outcomes manifest. An action-oriented research consortium headed up by the University of California and Universidad Nacional Autónoma de Mexico was constituted to set priorities for bi-national translational research, in an attempt to implement and evaluate clinical, public health and policy actions to decrease the burden of T2D for people of Mexican origin. In this paper, we describe the epidemiology of T2D in Mexico and California, review current efforts to combat the epidemic, highlight gaps in knowledge and identify urgent areas of opportunity for collaboration. The group has developed a common research agenda and funding has been obtained to evaluate biological samples from the 2016 Mexican Health Survey, collaborate in a telemedicine-based retinopathy project, implement interventions in food banks, promote a communications campaign, and design a large-scale diabetes prevention effectiveness trial. T2D has caused a state of emergency in Mexico and is a major health problem among Mexican populations on both sides of the border. Understanding the commonalities and differences between California and Mexico for those of Mexican origin with respect to T2D, when combined with a sharing of knowledge and advances, can produce a bi-national translational research agenda to inform relevant policy and practice. Amidst economic and political uncertainty and limited healthcare budgets, this collaboration can contribute to the development of scientific evidence to inform policies and interventions. This may provide a promising collaborative model that could be expanded to other health conditions and regions of the world.

1 June 2020 in The Journal of Nutrition
Verified
Journal Article
Closed access
LRLuis A Rodriguez
Luis A Rodriguez
YJYichen Jin
Yichen Jin
STSameera A. Talegawkar
Sameera A. Talegawkar
MOMarcia de Oliveira Otto
Marcia de Oliveira Otto
NKNamratha R Kandula
Namratha R Kandula
AKAlka M Kanaya
Alka M Kanaya
Diet quality is an important risk factor for type 2 diabetes (T2D) and cardiovascular disease (CVD). Little is known about the diet quality of South Asians in the United States, a group with higher rates of T2D and CVD compared with other racial/ethnic groups. This study determined whether diet quality differs between South Asian adults in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study and whites, Chinese Americans, African Americans, and Hispanics in the Multi-Ethnic Study of Atherosclerosis (MESA). Cross-sectional data from 3926 participants free of CVD from MESA visit 5 (2010-2011) and 889 South Asian participants from MASALA visit 1 (2010-2013) were pooled. Diet quality was assessed using the Alternative Healthy Eating Index (AHEI-2010) derived using FFQs. Multivariable linear regression models adjusted for age, sex, and total energy intake were used to compare mean differences in diet quality between the racial/ethnic groups. MESA participants were, on average, 14 y older than MASALA participants. The adjusted mean (95% CI) scores for the AHEI-2010 were 70.2 (69.5, 70.9) among South Asians, 66.2 (66.3, 68.2) among Chinese Americans, 61.1 (60.7, 61.6) among whites, 59.0 (58.4, 59.7) among Hispanics, and 57.5 (56.9, 58.1) among African Americans. The mean AHEI scores among South Asians were 3.1 (1.8, 4.3), 9.2 (8.3, 10.1), 11.2 (10.2, 12.3), and 12.8 (11.8, 13.7) points higher compared with Chinese Americans, whites, Hispanics, and African Americans, respectively. South Asian adults in the United States have a higher diet quality compared with other racial/ethnic groups. This paradoxical finding is not consistent with the observed higher rates of T2D and CVD compared with other groups. This is further evidence of the importance of studying the South Asian population to better understand the causes of chronic disease not explained by diet quality.

7 May 2024 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
LRLuis A. Rodriguez
Luis A. Rodriguez
HFHolly Finertie
Holly Finertie
RNRomain S. Neugebauer
Romain S. Neugebauer
BGBennett Gosiker
Bennett Gosiker
TTTainayah W. Thomas
Tainayah W. Thomas
JSJulie A. Schmittdiel
Julie A. Schmittdiel
Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) improve cardiorenal outcomes in patients with type 2 diabetes. Equitable use of SGLT2i and GLP-1 RA has the potential to reduce racial and ethnic health disparities. We evaluated trends in pharmacy dispensing of SGLT2i and GLP-1 RA by race and ethnicity. Retrospective cohort study of patients (≥18 years) with type 2 diabetes using 2014–2022 electronic health record data from six US care delivery systems. Entry was at earliest pharmacy dispensing of any type 2 diabetes medication. We used multivariable logistic regression to evaluate the association between pharmacy dispensing of SGLT2i and GLP1-RA and race and ethnicity. Our cohort included 687,165 patients (median 6 years of dispensing data; median 60 years; 0.3% American Indian/Alaska Native (AI/AN), 16.6% Asian, 10.5% Black, 1.4% Hawaiian or Pacific Islander (HPI), 31.1% Hispanic, 3.8% Other, and 36.3% White). SGLT2i was lower for AI/AN (OR 0.80, 95% confidence interval 0.68–0.94), Black (0.89, 0.86–0.92) and Hispanic (0.87, 0.85–0.89) compared to White patients. GLP-1 RA was lower for AI/AN (0.78, 0.63–0.97), Asian (0.50, 0.48–0.53), Black (0.86, 0.83–0.90), HPI (0.52, 0.46–0.57), Hispanic (0.69, 0.66–0.71), and Other (0.78, 0.73–0.83) compared to White patients. Dispensing of SGLT2is, and GLP-1 RAs was lower in minority group patients. There is a need to evaluate approaches to increase use of these cardiorenal protective drugs in patients from racial and ethnic minority groups with type 2 diabetes to reduce adverse cardiorenal outcomes and improve health equity. Patient-Centered Outcomes Research Institute and 10.13039/100000002 National Institutes of Health .

22 September 2020 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
LRL. A. Rodriguez
L. A. Rodriguez
PBP. T. Bradshaw
P. T. Bradshaw
SSS. C. Shiboski
S. C. Shiboski
AFA. Fernandez
A. Fernandez
EVE. Vittinghoff
E. Vittinghoff
AKA. M. Kanaya
A. M. Kanaya

19 July 2021 in Annals of Epidemiology
Verified
Journal Article
Closed access
LRLuis A. Rodriguez
Luis A. Rodriguez
AKAlka M. Kanaya
Alka M. Kanaya
SSStephen C. Shiboski
Stephen C. Shiboski
AFAlicia Fernandez
Alicia Fernandez
DHDavid Herrington
David Herrington
PBPatrick T. Bradshaw
Patrick T. Bradshaw

26 January 2021 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
LRLuis A. Rodriguez
Luis A. Rodriguez
SSStephen C. Shiboski
Stephen C. Shiboski
PBPatrick T. Bradshaw
Patrick T. Bradshaw
AFAlicia Fernandez
Alicia Fernandez
DHDavid Herrington
David Herrington
AKAlka M. Kanaya
Alka M. Kanaya